NCT00002838View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 31, 1995

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Leukemia
Interventions
BIOLOGICAL

Filgrastim (G-CSF)

DRUG

Cyclophosphamide

DRUG

Fludarabine Phosphate

PROCEDURE

Peripheral Blood Stem Cell Transplantation

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00002838 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter